Twinbeech Capital LP Buys New Position in Danaher Co. (NYSE:DHR)

Twinbeech Capital LP acquired a new stake in Danaher Co. (NYSE:DHR - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 155,627 shares of the conglomerate's stock, valued at approximately $35,724,000.

A number of other institutional investors also recently bought and sold shares of DHR. Vanguard Group Inc. boosted its holdings in shares of Danaher by 0.5% in the fourth quarter. Vanguard Group Inc. now owns 59,750,122 shares of the conglomerate's stock valued at $13,715,641,000 after acquiring an additional 315,912 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Danaher by 2.4% in the fourth quarter. Geode Capital Management LLC now owns 13,358,206 shares of the conglomerate's stock valued at $3,056,996,000 after acquiring an additional 315,446 shares in the last quarter. Norges Bank purchased a new stake in shares of Danaher in the fourth quarter valued at about $2,130,740,000. Bank of New York Mellon Corp boosted its holdings in shares of Danaher by 5.4% in the fourth quarter. Bank of New York Mellon Corp now owns 8,589,019 shares of the conglomerate's stock valued at $1,971,609,000 after acquiring an additional 441,012 shares in the last quarter. Finally, Northern Trust Corp boosted its holdings in shares of Danaher by 14.3% in the fourth quarter. Northern Trust Corp now owns 7,934,991 shares of the conglomerate's stock valued at $1,821,477,000 after acquiring an additional 992,594 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity at Danaher

In related news, Chairman Steven M. Rales sold 1,250,000 shares of the company's stock in a transaction that occurred on Monday, May 12th. The shares were sold at an average price of $196.74, for a total transaction of $245,925,000.00. Following the completion of the transaction, the chairman now owns 3,105,808 shares of the company's stock, valued at approximately $611,036,665.92. This represents a 28.70% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Christopher Paul Riley sold 15,805 shares of the firm's stock in a transaction that occurred on Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total transaction of $3,129,390.00. Following the completion of the transaction, the executive vice president now owns 15,179 shares in the company, valued at $3,005,442. The trade was a 51.01% decrease in their position. The disclosure for this sale can be found here. Insiders own 11.10% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts recently commented on the stock. JPMorgan Chase & Co. decreased their price objective on shares of Danaher from $280.00 to $260.00 and set an "overweight" rating on the stock in a report on Tuesday, April 22nd. UBS Group decreased their price objective on shares of Danaher from $275.00 to $240.00 and set a "buy" rating on the stock in a report on Wednesday, April 23rd. Robert W. Baird decreased their price objective on shares of Danaher from $231.00 to $225.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Wall Street Zen raised shares of Danaher from a "hold" rating to a "buy" rating in a report on Monday, May 12th. Finally, Jefferies Financial Group decreased their price objective on shares of Danaher from $260.00 to $230.00 and set a "buy" rating on the stock in a report on Tuesday, April 22nd. Four investment analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company. According to MarketBeat, Danaher has an average rating of "Moderate Buy" and an average price target of $263.24.

Danaher Trading Up 0.4%

Shares of DHR traded up $0.66 on Thursday, hitting $187.47. 3,097,232 shares of the stock traded hands, compared to its average volume of 3,470,141. Danaher Co. has a 1 year low of $171.00 and a 1 year high of $281.70. The stock's 50 day moving average is $196.07 and its two-hundred day moving average is $216.57. The firm has a market capitalization of $134.17 billion, a P/E ratio of 35.51, a P/E/G ratio of 2.66 and a beta of 0.80. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, topping analysts' consensus estimates of $1.62 by $0.26. Danaher had a return on equity of 10.82% and a net margin of 16.33%. The company had revenue of $5.74 billion for the quarter, compared to analyst estimates of $5.58 billion. As a group, sell-side analysts predict that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a $0.32 dividend. This represents a $1.28 annualized dividend and a yield of 0.68%. Danaher's payout ratio is currently 24.85%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.